Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines inc. - zanamivir - powder for inhalation - 5mg

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - combined diphtheria, tetanus and acellular pertussis, hepatitis b, inactivated poliomyelitis and haemophilus influenzae type b vaccine (preservative-free) - suspension for injection (i.m.)

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - hepatitis b (rdna) vaccine - suspension for i.m. injection (thiomersal-free/preservative-free) - 20mcg / ml

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - hepatitis b (rdna) vaccine - suspension for i.m. injection (thiomersal-free/preservative-free) - 10mcg + 0.5ml

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - haemophilus influenza type b conjugate vaccine - lyophilized powder for injection - 10mcg + 0.5ml

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines inc. - lamotrigine - dispersible/chewable tablet - 25 mg

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines inc. - topotecan (as hydrochloride) - capsule - 250 mcg

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines inc. - topotecan (as hydrochloride) - capsule - 1 mg

Philippines - English - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - lamotrigine - dispersible chewable tablet - 2mg

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - conjugate of streptococcus pneumoniae type 1 & haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 14 and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 18c and tetanus toxoid; conjugate of streptococcus pneumoniae type 19f and diphtheria toxoid; conjugate of streptococcus pneumoniae type 23f and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 4 and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 5 and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 6b and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 7f and haemophilus influenzae protein d; conjugate of streptococcus pneumoniae type 9v and haemophilus influenzae protein d; diphtheria toxoid (dt) carrier protein; polysaccharide (ps); protein-d (pd) carrier protein (derived from non-typeable haemophilus influenzae); tetanus toxoid (tt) carrier protein - injection, suspension - 1 μg ps1; 1.11-1.67 μg pd/dose - conjugate of streptococcus pneumoniae type 1 & haemophilus influenzae protein d 1 μg ps1; 1.11-1.67 μg pd/dose; conjugate of streptococcus pneumoniae type 14 and haemophilus influenzae protein d 1 μg ps14; 1.00-1.82 μg pd/dose; conjugate of streptococcus pneumoniae type 18c and tetanus toxoid 3 μg ps18c; 5.45-10.00 μg tt/dose; conjugate of streptococcus pneumoniae type 19f and diphtheria toxoid 3 μg ps19f; 3.33-6.00 μg dt/dose; conjugate of streptococcus pneumoniae type 23f and haemophilus influenzae protein d 1 μg ps23f; 0.39-0.74 μg pd/dose; conjugate of streptococcus pneumoniae type 4 and haemophilus influenzae protein d 3 μg ps4; 3.33-6.67 μg pd/dose; conjugate of streptococcus pneumoniae type 5 and haemophilus influenzae protein d 1 μg ps5; 0.67-1.25 μg pd/dose; conjugate of streptococcus pneumoniae type 6b and haemophilus influenzae protein d 1 μg ps6b; 0.56-0.95 μg pd/dose; conjugate of streptococcus pneumoniae type 7f and haemophilus influenzae protein d 1 μg ps7f; 0.87-1.43 μg pd/dose; conjugate of streptococcus pneumoniae type 9v and haemophilus influenzae protein d 1 μg ps9v; 1.00-1.82 μg pd/dose; diphtheria toxoid (dt) carrier protein 3-6 μg dt/dose (total dt content); polysaccharide (ps) 16 μg/dose (total ps content); protein-d (pd) carrier protein (derived from non-typeable haemophilus influenzae) 9-16 μg pd/dose (total pd content); tetanus toxoid (tt) carrier protein 5-10 μg/dose (total tt content)